Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13578-022-00912-5.

Title:
Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis | Cell & Bioscience
Description:
Early studies indicated that the androgen receptor (AR) could promote renal cell carcinoma (RCC) development and metastasis, but its linkage to RCC progression under hypoxia, remains unclear. Here we found AR expression in RCC cells decreased in response to hypoxia, which might then lead to increase the cancer stem cells (CSC) phenotype through the lncTCFL5-2-modulated YBX1/SOX2 signals. The consequences of such hypoxia-modulated AR/lncTCFL5-2/YBX1/SOX2 signals ablity to alter the CSC phenotype might render RCC cells more resistant to targeted therapy with Sunitinib. Mechanism dissection revealed that AR might alter the lncTCFL5-2/YBX1/SOX2 signaling through transcriptional suppression of the lncTCFL5-2 expression via the AR-response-elements (AREs) on the lncTCFL5-2 promoter. The lncTCFL5-2 interacts with YBX1 to increase its stability, which in turn increases SOX2 expression at a transcriptional level via the YBX1-response-elements (YBX1Es) on the SOX2 promoter. The in vivo mouse model with orthotopic xenografts of RCC cells also validates the in vitro data, and a human RCC sample survey demonstrated the clinical significance of the AR/lncTCFL5-2/YBX1/SOX2 signaling axis for the RCC prognosis, likely as a result of regulating CSC phenotypes. Together, these findings suggest that hypoxia may increase the RCC CSC phenotype via altering the AR/lncTCFL5-2/YBX1/SOX2 signaling axis and a potential therapy to target this newly identified signal perhaps may help improve the targeted therapy with Sunitinib to better suppress RCC progression.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Photography

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

cells, expression, hypoxia, rcc, fig, lnctcfl, cell, osrc, ybx, sox, formation, csc, article, pubmed, normoxia, cscs, tumor, cancer, analysis, days, google, scholar, exposed, transduced, results, additional, protein, lncrnas, phenotype, signaling, stem, progression, found, file, sunitinib, assay, cas, tissues, plasmid, data, level, oear, renal, performed, sphere, shlnctcfl, axis, therapy, patients, normal,

Topics {✒️}

hypoxia-modulated ar/lnctcfl5-2/ybx1/sox2 signals ablity ar/lnctcfl5-2/ybx1/sox2 signaling axis lnctcfl5-2-ybx1-sox2 signaling axis renal cell carcinoma org/db/gene/lnc-tcfl5-2 lnctcfl5-2-modulated ybx1/sox2 signals lncrnas including lnc-ctb-114c7 real-time rt-pcr assays cell stem cell heat-induced antigen retrieval ubiquitin-mediated degradation plays renal cell cancer cyclin-dependent kinases family sh-lnc-ctb-114c7 bio-rad cfx96 system human glyceraldehyde-3-phosphate dehydrogenase embryonic stem cell reduced proteasome-mediated degradation ar-modulated csc phenotype stem cell programs stem cell rev sh-lnctcfl5-2 suppresses tumorigenicity plasmid encoding ar-shrna1/2 renal cell carcinomas hrp-conjugated secondary antibodies lnctcfl5-2/ybx1/sox2 signaling supplement figures demonstrated quantitative real-time pcr article download pdf ar-suppressed cscs phenotypes goat anti-rat igg hypoxia-suppressed ar signaling human renal cancer hypoxia-induced csc phenotypes goat anti-mouse igg chi-ping huang cancer stem cells cancer stem-cells brain tumor-initiating cells monitor tumor growth androgen/ar signaling lnctcfl5-2/ybx1 complex translocates oe-ar oe-mutant lnctcfl5-2 lnc-ctb-114c7 osrc-2-luc cells suspended ar/lnctcfl5-2/ybx1 signals small renal masses signaling axis somatic stem cells cell growth

Questions {❓}

  • Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis
         description:Early studies indicated that the androgen receptor (AR) could promote renal cell carcinoma (RCC) development and metastasis, but its linkage to RCC progression under hypoxia, remains unclear. Here we found AR expression in RCC cells decreased in response to hypoxia, which might then lead to increase the cancer stem cells (CSC) phenotype through the lncTCFL5-2-modulated YBX1/SOX2 signals. The consequences of such hypoxia-modulated AR/lncTCFL5-2/YBX1/SOX2 signals ablity to alter the CSC phenotype might render RCC cells more resistant to targeted therapy with Sunitinib. Mechanism dissection revealed that AR might alter the lncTCFL5-2/YBX1/SOX2 signaling through transcriptional suppression of the lncTCFL5-2 expression via the AR-response-elements (AREs) on the lncTCFL5-2 promoter. The lncTCFL5-2 interacts with YBX1 to increase its stability, which in turn increases SOX2 expression at a transcriptional level via the YBX1-response-elements (YBX1Es) on the SOX2 promoter. The in vivo mouse model with orthotopic xenografts of RCC cells also validates the in vitro data, and a human RCC sample survey demonstrated the clinical significance of the AR/lncTCFL5-2/YBX1/SOX2 signaling axis for the RCC prognosis, likely as a result of regulating CSC phenotypes. Together, these findings suggest that hypoxia may increase the RCC CSC phenotype via altering the AR/lncTCFL5-2/YBX1/SOX2 signaling axis and a potential therapy to target this newly identified signal perhaps may help improve the targeted therapy with Sunitinib to better suppress RCC progression.
         datePublished:2022-11-17T00:00:00Z
         dateModified:2022-11-17T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13578-022-00912-5
         keywords:
            Hypoxia
            Renal cell carcinoma
            Cancer stem cells
            Androgen receptor
            lncTCFL5-2
            Cell Biology
            Microbiology
            Stem Cells
            Neurobiology
            Proteomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig7_HTML.png
         isPartOf:
            name:Cell & Bioscience
            issn:
               2045-3701
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Changcheng Guo
               affiliation:
                     name:Shanghai Tenth People’s Hospital, Tongji University
                     address:
                        name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                     address:
                        name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yin Sun
               affiliation:
                     name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                     address:
                        name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wei Zhai
               affiliation:
                     name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                     address:
                        name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                        type:PostalAddress
                     type:Organization
                     name:Renji Hospital, Shanghai Jiaotong University School of Medicine
                     address:
                        name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xudong Yao
               affiliation:
                     name:Shanghai Tenth People’s Hospital, Tongji University
                     address:
                        name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dongkui Gong
               affiliation:
                     name:Shanghai Tenth People’s Hospital, Tongji University
                     address:
                        name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                     address:
                        name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bosen You
               affiliation:
                     name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                     address:
                        name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chi-Ping Huang
               affiliation:
                     name:China Medical University/Hospital
                     address:
                        name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junhua Zheng
               affiliation:
                     name:Renji Hospital, Shanghai Jiaotong University School of Medicine
                     address:
                        name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Chawnshang Chang
               url:http://orcid.org/0000-0001-8510-3516
               affiliation:
                     name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                     address:
                        name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                        type:PostalAddress
                     type:Organization
                     name:China Medical University/Hospital
                     address:
                        name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis
      description:Early studies indicated that the androgen receptor (AR) could promote renal cell carcinoma (RCC) development and metastasis, but its linkage to RCC progression under hypoxia, remains unclear. Here we found AR expression in RCC cells decreased in response to hypoxia, which might then lead to increase the cancer stem cells (CSC) phenotype through the lncTCFL5-2-modulated YBX1/SOX2 signals. The consequences of such hypoxia-modulated AR/lncTCFL5-2/YBX1/SOX2 signals ablity to alter the CSC phenotype might render RCC cells more resistant to targeted therapy with Sunitinib. Mechanism dissection revealed that AR might alter the lncTCFL5-2/YBX1/SOX2 signaling through transcriptional suppression of the lncTCFL5-2 expression via the AR-response-elements (AREs) on the lncTCFL5-2 promoter. The lncTCFL5-2 interacts with YBX1 to increase its stability, which in turn increases SOX2 expression at a transcriptional level via the YBX1-response-elements (YBX1Es) on the SOX2 promoter. The in vivo mouse model with orthotopic xenografts of RCC cells also validates the in vitro data, and a human RCC sample survey demonstrated the clinical significance of the AR/lncTCFL5-2/YBX1/SOX2 signaling axis for the RCC prognosis, likely as a result of regulating CSC phenotypes. Together, these findings suggest that hypoxia may increase the RCC CSC phenotype via altering the AR/lncTCFL5-2/YBX1/SOX2 signaling axis and a potential therapy to target this newly identified signal perhaps may help improve the targeted therapy with Sunitinib to better suppress RCC progression.
      datePublished:2022-11-17T00:00:00Z
      dateModified:2022-11-17T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13578-022-00912-5
      keywords:
         Hypoxia
         Renal cell carcinoma
         Cancer stem cells
         Androgen receptor
         lncTCFL5-2
         Cell Biology
         Microbiology
         Stem Cells
         Neurobiology
         Proteomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-022-00912-5/MediaObjects/13578_2022_912_Fig7_HTML.png
      isPartOf:
         name:Cell & Bioscience
         issn:
            2045-3701
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Changcheng Guo
            affiliation:
                  name:Shanghai Tenth People’s Hospital, Tongji University
                  address:
                     name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                  address:
                     name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yin Sun
            affiliation:
                  name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                  address:
                     name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wei Zhai
            affiliation:
                  name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                  address:
                     name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                     type:PostalAddress
                  type:Organization
                  name:Renji Hospital, Shanghai Jiaotong University School of Medicine
                  address:
                     name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xudong Yao
            affiliation:
                  name:Shanghai Tenth People’s Hospital, Tongji University
                  address:
                     name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dongkui Gong
            affiliation:
                  name:Shanghai Tenth People’s Hospital, Tongji University
                  address:
                     name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                  address:
                     name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bosen You
            affiliation:
                  name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                  address:
                     name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chi-Ping Huang
            affiliation:
                  name:China Medical University/Hospital
                  address:
                     name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junhua Zheng
            affiliation:
                  name:Renji Hospital, Shanghai Jiaotong University School of Medicine
                  address:
                     name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Chawnshang Chang
            url:http://orcid.org/0000-0001-8510-3516
            affiliation:
                  name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
                  address:
                     name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
                     type:PostalAddress
                  type:Organization
                  name:China Medical University/Hospital
                  address:
                     name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell & Bioscience
      issn:
         2045-3701
      volumeNumber:12
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Shanghai Tenth People’s Hospital, Tongji University
      address:
         name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
         type:PostalAddress
      name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
      address:
         name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
         type:PostalAddress
      name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
      address:
         name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
         type:PostalAddress
      name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
      address:
         name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
         type:PostalAddress
      name:Renji Hospital, Shanghai Jiaotong University School of Medicine
      address:
         name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
         type:PostalAddress
      name:Shanghai Tenth People’s Hospital, Tongji University
      address:
         name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
         type:PostalAddress
      name:Shanghai Tenth People’s Hospital, Tongji University
      address:
         name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
         type:PostalAddress
      name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
      address:
         name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
         type:PostalAddress
      name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
      address:
         name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
         type:PostalAddress
      name:China Medical University/Hospital
      address:
         name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
         type:PostalAddress
      name:Renji Hospital, Shanghai Jiaotong University School of Medicine
      address:
         name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
         type:PostalAddress
      name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
      address:
         name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
         type:PostalAddress
      name:China Medical University/Hospital
      address:
         name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Changcheng Guo
      affiliation:
            name:Shanghai Tenth People’s Hospital, Tongji University
            address:
               name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
            address:
               name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Yin Sun
      affiliation:
            name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
            address:
               name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Wei Zhai
      affiliation:
            name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
            address:
               name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
               type:PostalAddress
            type:Organization
            name:Renji Hospital, Shanghai Jiaotong University School of Medicine
            address:
               name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Xudong Yao
      affiliation:
            name:Shanghai Tenth People’s Hospital, Tongji University
            address:
               name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Dongkui Gong
      affiliation:
            name:Shanghai Tenth People’s Hospital, Tongji University
            address:
               name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
            address:
               name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Bosen You
      affiliation:
            name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
            address:
               name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Chi-Ping Huang
      affiliation:
            name:China Medical University/Hospital
            address:
               name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      name:Junhua Zheng
      affiliation:
            name:Renji Hospital, Shanghai Jiaotong University School of Medicine
            address:
               name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Chawnshang Chang
      url:http://orcid.org/0000-0001-8510-3516
      affiliation:
            name:Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center
            address:
               name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
               type:PostalAddress
            type:Organization
            name:China Medical University/Hospital
            address:
               name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
      name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
      name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
      name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
      name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
      name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
      name:Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China
      name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
      name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
      name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan
      name:Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
      name:George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA
      name:Department of Urology, China Medical University/Hospital, Taichung, Taiwan

External Links {🔗}(156)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.84s.